Purpura fulminans on invasive meningococcal disease
DOI:
https://doi.org/10.5935/2764-734X.e202201006Keywords:
Meningococcal Infections, Neisseria meningitidis, Serogroup W-135, Purpura FulminansAbstract
Meningococcal disease has been responsible for millions of deaths in its epidemics worldwide. This report aims to highlight the rapid evolution of this currently less prevalent disease and its main complication, purpura fulminans, a rare and highly lethal syndrome, as well as to comment on its clinical and surgical management. This is a 23-year-old female healthcare professional who was diagnosed with meningoccemia caused by serogroup-W N. meningitidis, clinically progressing with purpura fulminans and subsequent need for amputation of the affected segments, in addition to other complications. The patient was not vaccinated for this serogroup, which would have avoided this serious condition - vaccination should be considered for the risk group to which she belonged. It’s an important case report in order to not forget diseases that are allegedly under control, but decades or centuries ago generated major health problems.
Downloads
References
1. Focaccia R. Doença meningocócica. In: Veronesi R, Focaccia R, eds. Tratado de infectologia. 5ª ed. São Paulo: Atheneu; 2015. p. 1053-66.
2. Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Situação epidemiológica da doença meningocócica, Brasil, 2007-2013. Boletim epidemiológico - volume 47, nº 29, 2016 [Internet]. Brasília (DF): Ministério da Saúde; 2020; [acesso em 2020 Dez 20]. Disponível em: https://www.gov.br/saude/pt-br/assuntos/boletins-epidemiologicos/numeros-anteriores
3. Ministério da Saúde (BR). Meningite [Internet]. Brasília (DF): Ministério da Saúde; 2020; [acesso em 2020 Dez 20]. Disponível em: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/m/meningite
4. Guiddir T, Gros M, Hong E, Terrade A, Denizon M, Deghmane AE, et al. Unusual initial abdominal presentations of invasive meningococcal disease. Clin Infect Dis. 2018 Oct;67(8):1220-7. DOI: https://doi.org/10.1093/cid/ciy257
5. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov;49(11):e1063-e43. DOI: https://doi.org/10.1097/CCM.0000000000005337
6. Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y, et al. Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Crit Care. 2010 Mar;14(2):R27. DOI: https://doi.org/10.1186/cc8898
7. Chalmers E, Cooper P, Forman K, Grimley C, Khair K, Minford A, et al. Purpura fulminans: recognition, diagnosis and management. Arch Dis Child. 2011;96(11):1066-71. DOI: https://doi.org/10.1136/adc.2010.199919
8. Colling ME, Bendapudi PK. Purpura fulminans: mechanism and management of dysregulated hemostasis. Transfus Med Rev. 2018 Apr;32(2):69-76. DOI: https://doi.org/10.1016/j.tmrv.2017.10.001
9. Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Departamento de Imunização e Doenças Transmissíveis. Coordenação-Geral do Programa Nacional de Imunizações. Manual dos centros de referência para imunobiológicos especiais [Internet]. 5ª ed. Brasília (DF): Ministério da Saúde; 2019; [acesso em 2020 Dez 20]. Disponível em: https://pesquisa.bvsalud.org/bvsms/resource/pt/mis-40552
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Infections in Evidence

This work is licensed under a Creative Commons Attribution 4.0 International License.
All users may freely read, download, share, and adapt this scientific product for any purpose (even commercial ones), provided that due credit is given to the authors and the original publication, and that any alterations are duly indicated.
> Ethics
All articles published herein have received ethical approval from the National Research Ethics System (formerly CEP/CONEP system) based on Federal Law 14.874/24 and other specific Brazilian regulations, or a similar document attesting to the knowledge and authorization from the institution of origin in the case of foreign works.
The authors declare that there is no sponsorship or conflict of interest of any kind, unless otherwise indicated in the body of the article.
It is worth noting that case reports are a valuable learning resource for the scientific community, but should not be used in isolation to guide diagnostic or therapeutic options in clinical practice or health policies














